ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Syneos Health Leaders Recognized by HBA

MORRISVILLE, N.C., May 17, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced that Jennifer Sozio, SVP Clinical Operations, FSP360, and Caitlin Purinai, Senior Director, Human Resources Business Partner, have been recognized by the Healthcare Businesswomen’s Association (HBA) as admirable female leaders in the healthcare industry.

“I am thrilled to see Jennifer Sozio and Caitlin Purinai recognized by the HBA for their outstanding performance and commitment to excellence,” said Michelle Keefe, CEO, Syneos Health. “Jennifer and Caitlin are role models for employees across the organization, representing women in healthcare who continuously deliver outstanding performance, demonstrate inclusive leadership, and are completely committed to customers, colleagues and the communities where we work and live. I’m honored to see this recognition by our long-standing HBA partner – demonstrating our shared alignment to empowering women worldwide.”

HBA is a global nonprofit organization comprised of individuals and organizations spanning the healthcare industry, committed to furthering the advancement and impact of women. Each year, the organization celebrates women leaders across the life sciences spectrum through their Corporate Partner employee recognition program.

In 2023, two Syneos Health female leaders are being recognized by the HBA in its Luminary Award and Rising Stars Award categories. Nominated by the HBA’s Corporate Partners, the Luminary Award recognizes women who serve as a role model in their company, actively mentoring and sponsoring others, and advancing other women’s careers through their dedication to the healthcare industry. The Rising Stars Award represents women in various career stages and disciplines who have demonstrated noteworthy achievements and proven attention to furthering their careers.

  • Jennifer Sozio, SVP, Clinical Operations, FSP360, has more than 25 years of experience in the industry and has been with Syneos Health for the last 14 years of her career. She has deep industry experience in clinical operations, project management and people management. Jennifer is passionate to change lives and helps build and grow global FSP teams for Syneos Health customers, accelerating our customers’ abilities to speed new therapies to patients.
  • Caitlin Purinai, Senior Director, Human Resources Business Partner for the Company’s Go-To-Market teams, has more than 13 years of experience in the industry. Caitlin brings a business-led approach to her human resources role with a strong focus on creating people strategies that maximize business outcomes and individual potential. Caitlin is passionate about building effective teams, developing talent and has an HR background in generalist and specialized roles. She has been instrumental in culture initiatives, including policy refinement, employee feedback forums and creating Diversity, Equity and Inclusion (DE&I) programs.

Syneos Health has been a member of the HBA for more than 20 years. This commitment is part of the organization’s DE&I focus, investing in women’s leadership, innovation and creativity across the biopharmaceutical sector.

“We value our HBA relationship and the customer conversations we host every day. Together, we are committed to changing patients’ lives by Shortening the distance from lab to life®.”

About Syneos Health
Syneos Health® (Nasdaq:SYNH) is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.  

We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. 
Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. 

Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.  

To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.

Investor Relations Contact: Press/Media Contact:
Ronnie Speight  Gary Gatyas
Senior Vice President, Investor RelationsExecutive Director, External Communications
+1 919 745 2745+1 908 763 3428
Investor.Relations@syneoshealth.com gary.gatyas@syneoshealth.com 


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.49
+0.00 (0.00%)
AAPL  259.88
+0.00 (0.00%)
AMD  202.68
+0.00 (0.00%)
BAC  47.90
+0.00 (0.00%)
GOOG  306.01
+0.00 (0.00%)
META  647.39
+0.00 (0.00%)
MSFT  409.41
+0.00 (0.00%)
NVDA  182.65
+0.00 (0.00%)
ORCL  151.56
+0.00 (0.00%)
TSLA  398.68
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.